ASC11
/ Ascletis
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
November 13, 2024
Study to Evaluate Safety, Tolerability, PK and the Food Effect on PK of ASC11/RTV Tablets in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=72 | Completed | Sponsor: Ascletis Pharmaceuticals Co., Ltd. | Recruiting ➔ Completed
Trial completion • Infectious Disease • Novel Coronavirus Disease
February 08, 2023
Study to Evaluate Safety, Tolerability, PK and the Food Effect on PK of ASC11/RTV Tablets in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=72 | Recruiting | Sponsor: Ascletis Pharmaceuticals Co., Ltd.
New P1 trial • Infectious Disease • Novel Coronavirus Disease
1 to 2
Of
2
Go to page
1